Likewise, other molecules including C-peptide, resistin, and C-cystatin also showed significantly lower levels (P < 0.05) in diabetes individuals taking metformin monotherapy compared to those that are under Glipizide monotherapy (Supplementary Figure 3). The gene discussed is CST3; the disease is diabetes mellitus.